Teriparatide
Payments companies reported to CMS as associated with Teriparatide. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Teriparatide, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Teriparatide
These are the largest totals companies reported as associated with Teriparatide. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Theresa Falk | Hamilton, OH | Family | $475.89 |
| Jacqueline Kernaghan | Springfield, PA | Medical | $418.08 |
| Amanda Dixon | Mason, OH | Family | $412.51 |
| Jaime Pachon | South Miami, FL | Rheumatology | $389.17 |
| Margarita Garces | South Miami, FL | Rheumatology | $388.76 |
| Stuart Silverman | Beverly Hills, CA | $377.73 | |
| Patricia Mueller | South Miami, FL | Rheumatology | $363.38 |
| Anan Faidi | Stockton, CA | Endocrinology, Diabetes & Metabolism | $340.98 |
| Son Bach | Mason, OH | Family Medicine | $339.56 |
| Alaysha Germosen | Cincinnati, OH | Family | $333.72 |
Prescribed Teriparatide?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.